Hôpital Universitaire Dupuytren

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30)	Patients With High-risk MIBC	Active, not recruiting	Not applicable	2024-12-04		NCT03333356

Clinical trials